Article

Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards

Pediatric Dengue Vaccine Initiative, International Vaccine Institute, Seoul, Republic of Korea.
PLoS Neglected Tropical Diseases (Impact Factor: 4.49). 11/2010; 4(11):e890. DOI: 10.1371/journal.pntd.0000890
Source: PubMed

ABSTRACT Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world.
We invited dengue experts from around the world to attend meetings to discuss dengue surveillance. We reviewed literature, heard detailed reports on surveillance programs, and shared expert opinions.
Presentations by 22 countries were heard during the 2.5 day meetings. We describe the best methods of surveillance in general, the stakeholders in dengue surveillance, and the steps from mosquito bite to reporting of a dengue case to explore how best to carry out dengue surveillance. We also provide details and a comparison of the dengue surveillance programs by the presenting countries.
The experts provided recommendations for achieving the best possible data from dengue surveillance accepting the realities of the real world (e.g., limited funding and staff). Their recommendations included: (1) Every dengue endemic country should make reporting of dengue cases to the government mandatory; (2) electronic reporting systems should be developed and used; (3) at minimum dengue surveillance data should include incidence, hospitalization rates, deaths by age group; (4) additional studies should be completed to check the sensitivity of the system; (5) laboratories should share expertise and data; (6) tests that identify dengue virus should be used in patients with fever for four days or less and antibody tests should be used after day 4 to diagnose dengue; and (7) early detection and prediction of dengue outbreaks should be goals for national surveillance systems.

Download full-text

Full-text

Available from: Richard T Mahoney, Aug 14, 2015
0 Followers
 · 
153 Views
  • Source
    • "Reported DF in Medellin climbed from 341 cases in 2009 to 17,456 in 2010, reflecting an increased incidence from 17.2 to 745.4 per 100,000 inhabitants, respectively (http://www.dssa.gov.co/). While surveillance programs have been established to track epidemics and circulating strains, the true disease burden is underestimated due the focus on hospitalized DHF cases in most national surveillance systems [4]. Milder forms of dengue infection, which represent the largest proportion of cases, may also be misdiagnosed by treating physicians. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A dengue fever surveillance study was conducted at three medical facilities located in the low-income district of San Javier in Medellin, Colombia. During March 2008 to 2009, 781 patients with fever regardless of chief complaint were recruited for acute dengue virus infection testing. Of the 781 tested, 73 (9.3%) were positive for dengue infection. Serotypes DENV-2 (77%) and -3 (23%) were detected by PCR. One patient met the diagnostic criteria for dengue hemorrhagic fever. Only 3 out of 73 (4.1%) febrile subjects testing positive for dengue infection were diagnosed with dengue fever by the treating physician. This study confirms dengue virus as an important cause of acute febrile illness in Medellin, Colombia, but it is difficult to diagnose without dengue diagnostic testing.
    Journal of Tropical Medicine 05/2014; 2014:872608. DOI:10.1155/2014/872608
  • Source
    • "Dengue virus (DENV) infection is the wildest mosquito born infection affecting 2.5 billion people of tropical and sub-tropical regions of the world [1] [2] . Dengue virus is a member of Flaviviridae family and is transmitted to humans by infected female of Aedes genus, especially Aedes aegypti or Aedes albopictus mosquito [3] [4] . There are 4 serotypes of dengue virus (DENV 1-4) that manifest with similar symptoms [5] [6] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dengue virus infection has become a global threat affecting around 100 countries in the world. Currently, there is no licensed antiviral agent available against dengue. Thus, there is a strong need to develop therapeutic strategies that can tackle this life threatening disease. RNA interference is an important and effective gene silencing process which degrades targeted RNA by a sequence specific process. Several studies have been conducted during the last decade to evaluate the efficiency of siRNA in inhibiting dengue virus replication. This review summarizes siRNAs as a therapeutic approach against dengue virus serotypes and concludes that siRNAs against virus and host genes can be next generation treatment of dengue virus infection.
    Asian Pacific Journal of Tropical Biomedicine 03/2013; 3(3):232-6. DOI:10.1016/S2221-1691(13)60057-X
  • Source
    • "A recent opinion article published in an Indian journal (Sivagnaname et al. 2012) has raised some issues attracting the attention to develop a permanent surveillance system in India. However, these issues have been addressed by many authors and they have provided important suggestions for the development of best surveillance system for dengue (Beatty et al. 2010; Bhattacharjee and Bhattacharjee 2011; Prasad et al. 2010; Sivagnaname et al. 2012) that could effectively contribute in dengue control. Moreover, WHO 1370 Parasitol Res (2013) 112:1367–1378 Author's personal copy h a s i d e n t i f i e d t h i s p r o b l e m and has already started DengueNet an internet based central data management system (http:// www.who.int/csr/disease/dengue/denguenet/en/ "
    [Show abstract] [Hide abstract]
    ABSTRACT: At the end of the last century, India has faced resurgence of many infectious diseases, of which dengue is one of the most important in terms of morbidity and mortality. The National Vector Borne Disease Control Program data show that dengue is established in India and is becoming endemic to many areas (dengue cases have increased steadily from ∼450 to ∼50,000 from 2000 to 2012). Despite extensive efforts being made in developing the effective dengue control measures, the number of dengue cases, their severity, and geographical boundaries are expanding alarmingly and posing dengue as one of the deadly disease. Recently, the increasing burden of dengue in the country has attracted the scientific as well as Indian Government's administrative attention; however, a lot remain to be achieved for managing the disease under threshold level. Like other vector-borne diseases, better management of the dengue needs balanced approach involving various aspects like disease prevention, cure/treatment, and the vector control, simultaneously. We have briefly discussed here the situation of dengue in India and have tried to highlight the worrying facets of dengue control and its implementation in Indian perspective. The review on various aspects of dengue control has revealed an urgent need for permanent surveillance programs, coupled with improvised disease diagnostics, effective anti-dengue treatment measures, and controlling the disease transmission by following an effective implementation of vector control programs.
    Parasitology Research 02/2013; DOI:10.1007/s00436-013-3342-2 · 2.33 Impact Factor
Show more